A carregar...
Publicação
The decade of the kidney - benefitting from unhealthy lifestyles
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 792.07 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
The equity research report of Fresenius Medical Care
results in a “BUY” recommendation of FME stock with
expected returns of 57.4% until end-of-2023.
Descrição
Palavras-chave
Equity research report Fresenius medical care Health care sector Renal care market Dialysis services Dialysis products